Back
Biogen Vs. Bristol-Myers Squibb Industry Stock Comparison
Buy
51
BIIB
Biogen
Last Price:
223.78
Seasonality Move:
6.6%
Sell
40
BMY
Bristol-Myers Squibb
Last Price:
45.12
Seasonality Move:
0.31%
Buy
51
Biogen (BIIB)
is a Buy
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $221.50. The Score for BIIB is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- BIIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $44.94. The Score for BMY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $44.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.61 | Buy |
| Relative Strength Index (14 RSI): | 63.27 | Buy |
| Chaikin Money Flow: | -159505 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (196.15 - 217.19) | Buy |
| Bollinger Bands (100): | (207.93 - 247.97) | Sell |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.64 | Sell |
| Relative Strength Index (14 RSI): | 37.37 | Sell |
| Chaikin Money Flow: | 7844493 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.23 - 49.41) | Sell |
| Bollinger Bands (100): | (47.43 - 52.61) | Sell |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 218.96 | Buy |
| 20-day SMA: | 207.59 | Buy |
| 50-day SMA: | 212.05 | Buy |
| 200-day SMA: | 240.46 | Sell |
| 8-day EMA: | 218.34 | Buy |
| 20-day EMA: | 212.92 | Buy |
| 50-day EMA: | 214.56 | Buy |
| 200-day EMA: | 236.75 | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.15 | Buy |
| 20-day SMA: | 46.01 | Sell |
| 50-day SMA: | 49.65 | Sell |
| 200-day SMA: | 53.16 | Sell |
| 8-day EMA: | 44.56 | Buy |
| 20-day EMA: | 45.95 | Sell |
| 50-day EMA: | 48.22 | Sell |
| 200-day EMA: | 53.43 | Sell |
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.03 per share, an increase this year of $0.62 per share, and an increase next year of $1.73 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.22 per share, a decrease this year of $6.86 per share, and an increase next year of $6.41 per share.
Biogen Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||